epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Alyacen 7/ 7/ 7
    norethindrone/ ethinyl estradiol
  • remove edamame
    soy (Glycine max)
  • remove GoLytely
    polyethylene glycol/ electrolytes
  • remove Lampit
    nifurtimox
  • remove saw palmetto (Serenoa repens)
    common name
  • remove Vicks Sinex Severe All-in-One Sinus
    acetaminophen/ phenylephrine

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Alyacen 7/7/7 (norethindrone/ ethinyl estradiol) + Vicks Sinex Severe All-in-One Sinus (acetaminophen/ phenylephrine)

Monitor/Modify Tx


ethinyl estradiol (contraceptive) + acetaminophen

monitor thrombosis s/sx: combo may incr. ethinyl estradiol levels, risk of thromboembolism, other adverse effects (mechanism unknown)

ethinyl estradiol (contraceptive) + phenylephrine

monitor BP: combo may incr. risk of HTN (additive effects)

Additional Considerations

Smiley face Smiley face polyethylene glycol/electrolytes in GoLytely

separate administration from other oral drugs by at least 1h; polyethylene glycol/electrolytes may decr. absorption of concomitant oral drugs

Smiley face Smiley face phenylephrine in Vicks Sinex Severe All-in-One Sinus

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information